Biden Covid’s response team maintains instructions after J&J requests FDA approval for the vaccine

[The stream is slated to start at 11 a.m. ET. Please refresh the page if you do not see a player above at that time.]

President Joe Biden’s Covid-19 response team is holding a meeting on Friday about the coronavirus pandemic, which claimed the lives of at least 455,875 Americans.

The briefing comes a day after Johnson & Johnson said it asked the Food and Drug Administration to authorize its single-dose vaccine Covid-19 for emergency use in the U.S. The FDA scheduled a meeting of its Vaccine and Related Biological Products Advisory Committee on February 26 to discuss the vaccine, which may be distributed in the United States later this month.

Federal and state officials are eagerly awaiting authorization for the J&J vaccine. Unlike Pfizer and Moderna vaccines, which require two doses administered every three to four weeks, J&J medication requires only one dose, facilitating logistics for healthcare professionals.

Read CNBC’s live updates to see the latest news on the Covid -19 outbreak.

.Source